Placental-type alkaline phosphatase in peritoneal fluid of women with endometriosis
Other
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
This study investigated placental-type alkaline phosphatase (PLAP) levels in peritoneal fluid from women with endometriosis and found it to be a potential biomarker for the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Alkaline phosphatase (ALP) activities were studied in peritoneal fluid obtained from patients with untreated endometriosis and control women who had normal pelves. The patients (n = 18) had significantly higher total ALP (8.65 +/- 5.69 mU/mg, p less than 0.01) and thermostable ALP (0.28 +/- 0.23 mU/mg, p less than 0.05) than the controls (n = 7) (total ALP = 2.41 +/- 1.15; thermostable ALP = 0.09 +/- 0.04 mU/mg). The contents of the thermostable ALP in the total ALP were 4.5 +/- 2.4% for controls and 3.6 +/- 2.3% for patients. To define the biochemical characteristics of the thermostable ALP, the enzyme was partially purified from a mixture of peritoneal fluid from 16 patients. The partially purified, heated ALP (PFALP) responded to the various inhibitors, activators, and pH values tested in a significantly similar manner as a purified, heated human placental ALP did. Our data suggest that PFALP may be a placental-type (or Regan) ALP.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (31)
- Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F via openalex
- Enzyme-linked immunosorbent assay of CA-125 in serum of patients with endometriosis: efficacy in diagnosis via openalex
- Etiological factors of endometriosis via openalex
- The basement membrane in endometriosis via openalex
- W1991833534 via openalex
- W1996039432 via openalex
- W1998169975 via openalex
- W2015519036 via openalex
- W2026281998 via openalex
- W2040471575 via openalex
- W2061451528 via openalex
- W2074412443 via openalex
- W2092774804 via openalex
- W2095722308 via openalex
- W2102719470 via openalex
- W2104961116 via openalex
- W2145480596 via openalex
- W2157906061 via openalex
- W2283760758 via openalex
- W2408859805 via openalex
- W2477008945 via openalex
- W4206110044 via openalex
- W6654204593 via openalex
- W6666230023 via openalex
- W6674452497 via openalex
- W6675793441 via openalex
- W42372792 via openalex
- W6812549519 via openalex
- W60401492 via openalex
- W1775749144 via openalex
- W1982588383 via openalex
Cited by (5)
- Diagnostic utility of Synuclein gamma (SNCG) and b-cell Lymphoma 6 (BCL6) as potential non-invasive dual biomarkers for endometriosis 2025
- Clinical diagnosis model Construction of endometriosis based on clinical data* 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- Application of serum markers in diagnosis and staging of ovarian endometriosis 2021
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:11:01.534134+00:00
- unpaywall
- last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0
· commercial use OK